Rheumatoid Arthritis Drugs Market Revenue 2024 to 2034
Rheumatoid Arthritis Drugs Market Revenue 2024 to 2034
The rheumatoid arthritis drugs market is projected to reach USD 29.31 billion by 2034, growing from USD 19.55 billion in 2025, at a CAGR of 4.6% during the forecast period from 2025 to 2034.
Report ID: 10151
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 18.69 Bn
Forecast Year,
USD USD 29.31 Bn
CAGR, 2025 -
4.6%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Rheumatoid Arthritis Drugs Market Size Analysis
Rheumatoid Arthritis Drugs Market Size By Drug Type 2024 to 2034 (USD )
| Drug Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmaceuticals | 14.68 | 15.19 | 16.05 | 16.56 | 17.35 | 17.98 | 18.89 | 19.83 | 20.61 | 22.10 | 22.85 |
| Biopharmaceuticals | 4.01 | 4.35 | 4.40 | 4.83 | 5.03 | 5.42 | 5.59 | 5.77 | 6.17 | 5.91 | 6.45 |
Rheumatoid Arthritis Drugs Market Size By Distribution Channel 2024 to 2034 (USD )
| Distribution Channel | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacy | 7.59 | 8.27 | 8.88 | 9.45 | 9.64 | 10.14 | 11.08 | 11.09 | 11.62 | 11.64 | 12.17 |
| Retail Pharmacy | 3.00 | 2.82 | 2.91 | 2.97 | 3.11 | 3.32 | 3.33 | 3.84 | 3.86 | 4.46 | 4.57 |
| Online Pharmacy | 8.10 | 8.45 | 8.66 | 8.98 | 9.63 | 9.95 | 10.07 | 10.67 | 11.30 | 11.92 | 12.56 |
Rheumatoid Arthritis Drugs Market Size By Route of Administration 2024 to 2034 (USD )
| Route of Administration | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oral | 6.13 | 6.62 | 6.79 | 7.01 | 7.45 | 8.07 | 8.21 | 8.67 | 9.05 | 9.70 | 9.65 |
| Parenteral | 6.66 | 6.85 | 7.12 | 7.36 | 7.84 | 8.26 | 8.21 | 8.86 | 9.53 | 9.68 | 10.30 |
| Topical | 5.90 | 6.09 | 6.55 | 7.02 | 7.08 | 7.08 | 8.06 | 8.07 | 8.20 | 8.64 | 9.35 |
Rheumatoid Arthritis Drugs Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 1.33 | 0.93 | 1.15 | 1.17 | 0.98 | 1.43 | 1.69 | 1.82 | 1.11 | 1.53 | 2.00 |
| Europe | 2.42 | 2.48 | 2.61 | 2.83 | 2.56 | 3.23 | 2.80 | 2.92 | 3.32 | 3.09 | 3.91 |
| Asia-Pacific | 2.32 | 3.07 | 3.19 | 2.95 | 3.68 | 3.22 | 3.12 | 3.76 | 4.08 | 3.89 | 4.34 |
| Latin America | 2.92 | 2.86 | 2.80 | 3.01 | 3.52 | 3.13 | 3.96 | 3.69 | 4.05 | 4.57 | 3.89 |
| Middle East & Africa | 9.70 | 10.22 | 10.70 | 11.43 | 11.63 | 12.40 | 12.91 | 13.41 | 14.22 | 14.94 | 15.17 |
Rheumatoid Arthritis Drugs Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
